Literature DB >> 2548758

Prostaglandin E receptors in cardiac sarcolemma. Identification and coupling to adenylate cyclase.

G D Lopaschuk1, M Michalak, E L Wandler, R W Lerner, T D Piscione, F Coceani, P M Olley.   

Abstract

Purified cardiac sarcolemmal membrane vesicles were used to determine if specific prostaglandin (PG) receptors are present on the myocyte. Two binding sites for PGE2 were identified in isolated bovine sarcolemmal membranes: a high-affinity site with a dissociation constant (Kd) of 0.32 nM and a maximum binding (Bmax) of 376 fmol/mg of protein and a lower-affinity site with a Kd of 3.41 nM and a Bmax of 2,112 fmol/mg of protein. In competition experiments, unlabeled PGE1 displaced [3H]PGE2 from its membrane receptor at concentrations similar to those of unlabeled PGE2. Both PGF2 alpha and PGD2 displaced [3H]PGE2 from the membrane, but only at high concentrations (greater than 10(-6) M and greater than 10(-5)M, respectively). Digestion of sarcolemmal membrane with trypsin resulted in a threefold decrease in specific [3H]PGE2 binding. Phosphorylation of the membrane with protein kinase A also decreased specific [3H]PGE2 binding. At concentrations of PGE2 that occupy the high-affinity site, sarcolemmal adenylate cyclase activity was inhibited in the presence of 5'-guanylylimidodiphosphate [Gpp(NH)p]. We conclude that the isolated cardiac sarcolemmal membrane contains a high-affinity binding site for PGE2 that is functionally coupled to adenylate cyclase. The binding site is stereospecific and probably recognizes the 9-keto,11-hydroxyl portion of the ring structure of these prostaglandins.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2548758     DOI: 10.1161/01.res.65.3.538

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  6 in total

1.  Subfractionation of cardiac sarcolemma with wheat-germ agglutinin.

Authors:  J H Charuk; S Howlett; M Michalak
Journal:  Biochem J       Date:  1989-12-15       Impact factor: 3.857

2.  Cyclic AMP suppresses the inhibition of glycolysis by alternative oxidizable substrates in the heart.

Authors:  C Depre; S Ponchaut; J Deprez; L Maisin; L Hue
Journal:  J Clin Invest       Date:  1998-01-15       Impact factor: 14.808

Review 3.  Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning.

Authors:  Roberto Bolli; Ken Shinmura; Xian-Liang Tang; Eitaro Kodani; Yu-Ting Xuan; Yiru Guo; Buddhadeb Dawn
Journal:  Cardiovasc Res       Date:  2002-08-15       Impact factor: 10.787

4.  Sulprostone-induced reduction of myocardial infarct size in the rabbit by activation of ATP-sensitive potassium channels.

Authors:  E J Hide; C Thiemermann
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

5.  Reduction by prostaglandin E1 or prostaglandin E0 of myocardial infarct size in the rabbit by activation of ATP-sensitive potassium channels.

Authors:  E J Hide; P Ney; J Piper; C Thiemermann; J R Vane
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

6.  Inotropic actions of eicosanoids.

Authors:  K Schrör; T Hohlfeld
Journal:  Basic Res Cardiol       Date:  1992 Jan-Feb       Impact factor: 17.165

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.